Half of women with Rh disease lack treatment, leading to over 100,000 deaths

In Nairobi, Kenya, on December 11, 2024, BSV has initiated an awareness campaign called "Voice of Africa" aimed at increasing awareness about Hemolytic Disease of the Fetus and Newborn (HDFN) due to the Rh factor. The Rh factor is a significant health concern when Rh-negative women come into contact with Rh-positive blood, which can occur during pregnancy and lead to severe complications for the baby. This situation has been exacerbated by reports indicating that only half of the women globally receive necessary treatment for Rh disease. The lack of proper access to Rh immunoglobulin therapy is a critical barrier preventing effective prevention and management of this serious condition. Dr. Moses Obimbo, associated with the University of Nairobi, highlighted that the prevalence of Rh-negative blood types among pregnant women in Kenya is much higher than previously documented, at approximately 6-10% in various counties—a stark contrast to the previously accepted 4%. This variance underscores the urgent need for increased awareness, testing, and subsequent treatment in the region as the number of women potentially needing treatment grows. It reflects the necessity for healthcare policies that support the expansion of screening and treatment options for Rh incompatibility. A statement from BSV notes that education on self-awareness, including knowledge of one’s own blood type, is crucial for reducing risks associated with Rh sensitization. Effective antenatal care, which includes administering Rh immunoglobulin injections during specific circumstances in pregnancy, is vital in mitigating the risks of Rh disease. The push for better healthcare access is supported by the Government of Tanzania, which prioritizes maternal and child health. Dr. Matilda Ngarina, president of the Association of Gynecologists and Obstetricians of Tanzania (AGOTA), emphasizes the importance of improving antenatal care services to enhance health outcomes for mothers and infants. The overall focus of this initiative is to significantly raise awareness about Rh disease across African countries, leveraging both local and international healthcare partnerships to ensure that women receive the education and medical care necessary to safeguard their pregnancies. By doing so, the campaign aims to reduce the mortality rate associated with Rh disease, ultimately protecting numerous lives and improving maternal health across the continent.